India, April 15 -- The Competition Commission of India has approved the proposed transaction involving Aster DM Healthcare, BCP Asia, Centella and Quality Care India Limited.The proposed transaction includes the proposed merger of Quality Care India Limited (QCIL) into Aster DM Healthcare Limited (Aster) by way of scheme of amalgamation, post which Aster will be renamed as Aster DM Quality Care Limited. Prior to the merger, Aster shall purchase 5.0% stake in QCIL from BCP Asia II TopCo IV Pte. Ltd. (BCP Asia) and Centella Mauritius Holdings Limited (Centella) in consideration of a primary share issuance by Aster. The existing shareholders of QCIL i.e., Centella, BCP and certain minority shareholders are proposed to hold certain stake in the...